Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Neuroendocrine Tumor Research Advances, and Pancreatitis Pathology and Treatment.
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non‐Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols
DNA Methylation Profiling Enables Accurate Classification of Nonductal Primary Pancreatic Neoplasms
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap
Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities
Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes
Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma
Transarterial Embolization of Liver Cancer in a Transgenic Pig Model
Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy
Gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
Intracholecystic tubular non-mucinous neoplasm (ICTN) of the gallbladder: a clinicopathologically distinct, invasion-resistant entity
Non-neoplastic Polyps of the Gallbladder
Sclerosing epithelioid mesenchymal neoplasm of the pancreas – a proposed new entity
Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer